JP2023519925A - フォルスコリン誘導性プロモーター及び低酸素誘導性プロモーター - Google Patents

フォルスコリン誘導性プロモーター及び低酸素誘導性プロモーター Download PDF

Info

Publication number
JP2023519925A
JP2023519925A JP2022558590A JP2022558590A JP2023519925A JP 2023519925 A JP2023519925 A JP 2023519925A JP 2022558590 A JP2022558590 A JP 2022558590A JP 2022558590 A JP2022558590 A JP 2022558590A JP 2023519925 A JP2023519925 A JP 2023519925A
Authority
JP
Japan
Prior art keywords
seq
sequence
campre
cells
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022558590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023519925A5 (cg-RX-API-DMAC7.html
Inventor
グラハム・ホワイトサイド
ヴィクトリア・フィオナ・トーランス
マイケル・エル・ロバーツ
Original Assignee
アスクレピオス バイオファーマシューティカル, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2005473.0A external-priority patent/GB202005473D0/en
Priority claimed from GBGB2005475.5A external-priority patent/GB202005475D0/en
Priority claimed from GBGB2101969.0A external-priority patent/GB202101969D0/en
Priority claimed from GBGB2101972.4A external-priority patent/GB202101972D0/en
Application filed by アスクレピオス バイオファーマシューティカル, インコーポレイテッド filed Critical アスクレピオス バイオファーマシューティカル, インコーポレイテッド
Publication of JP2023519925A publication Critical patent/JP2023519925A/ja
Publication of JP2023519925A5 publication Critical patent/JP2023519925A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2022558590A 2020-03-26 2021-03-26 フォルスコリン誘導性プロモーター及び低酸素誘導性プロモーター Pending JP2023519925A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202063000155P 2020-03-26 2020-03-26
US63/000,155 2020-03-26
US202063010330P 2020-04-15 2020-04-15
GB2005475.5 2020-04-15
GBGB2005473.0A GB202005473D0 (en) 2020-04-15 2020-04-15 Forskolin-inducible promoters
GBGB2005475.5A GB202005475D0 (en) 2020-04-15 2020-04-15 Hypoxia-inducible promoters
GB2005473.0 2020-04-15
US63/010,330 2020-04-15
GB2101972.4 2021-02-12
GBGB2101969.0A GB202101969D0 (en) 2021-02-12 2021-02-12 Hypoxia inducible promoters
GBGB2101972.4A GB202101972D0 (en) 2021-02-12 2021-02-12 Forskolin inducible promoters
GB2101969.0 2021-02-12
PCT/GB2021/050743 WO2021191628A1 (en) 2020-03-26 2021-03-26 Forskolin-inducible promoters and hypoxia-inducible promoters

Publications (2)

Publication Number Publication Date
JP2023519925A true JP2023519925A (ja) 2023-05-15
JP2023519925A5 JP2023519925A5 (cg-RX-API-DMAC7.html) 2024-03-22

Family

ID=77890128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022558590A Pending JP2023519925A (ja) 2020-03-26 2021-03-26 フォルスコリン誘導性プロモーター及び低酸素誘導性プロモーター

Country Status (7)

Country Link
US (1) US20230374526A1 (cg-RX-API-DMAC7.html)
EP (1) EP4127180A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023519925A (cg-RX-API-DMAC7.html)
CN (1) CN115698300A (cg-RX-API-DMAC7.html)
AU (1) AU2021240417A1 (cg-RX-API-DMAC7.html)
CA (1) CA3171636A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021191628A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025015211A1 (en) * 2023-07-12 2025-01-16 Georgia Tech Research Corporation Synthetic genetic constructs that induce gene expression in response to tumor-specific metabolic alterations
WO2025090555A1 (en) * 2023-10-23 2025-05-01 University Of Southern California Ultrasound-controlled car t with sensitive evolved promoter and feedback integration and uses thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038118A1 (fr) * 2001-10-31 2003-05-08 Fujisawa Pharmaceutical Co., Ltd. Methode d'evaluation d'inhibiteurs de la phosphatase
JP2003528624A (ja) * 2000-03-24 2003-09-30 エッペンドルフ アレイ テクノロジーズ エス.エー. 転写因子のスクリーニング、検出および/または定量方法およびキット
US20060127371A1 (en) * 2002-11-25 2006-06-15 Peppelenbosch Maikel P ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells
US20100273865A1 (en) * 2007-11-02 2010-10-28 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Polypeptides involved in neuronal regeneration-associated gene expression
US20110065100A1 (en) * 2009-09-16 2011-03-17 SwitchGear Genomics, Inc., a Delaware Corporation Transcription biomarkers of biological responses and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB9206874D0 (en) * 1992-03-30 1992-05-13 Connaught Lab Generation of improved inducible mammalian expression vectors
IT1258959B (it) 1992-06-09 1996-03-11 Impianto a moduli mobili per lo sviluppo e la produzione di prodotti biotecnologici su scala pilota
JP2007520820A (ja) 2004-02-03 2007-07-26 エクセラーエックス, エルエルシー 製造のためのシステムおよび方法
CN101001945B (zh) 2004-06-04 2012-02-08 艾克塞勒雷克斯公司 一次性生物反应器系统及方法
US20080206817A1 (en) 2004-12-07 2008-08-28 Johann Brass Rhamnose Promoter Expression System
US20090305626A1 (en) 2005-12-05 2009-12-10 Hope Ernest G Prevalidated, modular good manufacturing practice-compliant facility
WO2011139708A2 (en) 2010-04-26 2011-11-10 Toyota Motor Engineering & Manufacturing North America, Inc. Improved hydrogen release from complex metal hydrides by solvation in ionic liquids
US10371394B2 (en) 2010-09-20 2019-08-06 Biologics Modular Llc Mobile, modular cleanroom facility
US9388373B2 (en) 2011-03-08 2016-07-12 University Of Maryland Baltimore County Microscale bioprocessing system and method for protein manufacturing
KR102128957B1 (ko) 2011-10-07 2020-07-02 론자 리미티드 조절가능한 프로모터
MY172311A (en) * 2012-08-02 2019-11-21 Univ Putra Malaysia Hypoxia inducible factor (hif) activity reporter cell line
AU2018215537B2 (en) * 2017-02-03 2023-11-09 Manus Bio, Inc. Metabolic engineering for microbial production of terpenoid products
CN110582574A (zh) * 2017-03-13 2019-12-17 麻省理工学院 合成启动子
CN107523588B (zh) * 2017-08-18 2020-08-07 深圳大学 一种四环素慢病毒诱导表达载体及其建立方法和应用
GB201713545D0 (en) * 2017-08-23 2017-10-04 Synpromics Ltd Expression control using a regulatable intron
WO2021158658A1 (en) * 2020-02-04 2021-08-12 The Board Of Trustees Of The Leland Stanford Junior University Split crispr-cas for biological signal integration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003528624A (ja) * 2000-03-24 2003-09-30 エッペンドルフ アレイ テクノロジーズ エス.エー. 転写因子のスクリーニング、検出および/または定量方法およびキット
WO2003038118A1 (fr) * 2001-10-31 2003-05-08 Fujisawa Pharmaceutical Co., Ltd. Methode d'evaluation d'inhibiteurs de la phosphatase
US20060127371A1 (en) * 2002-11-25 2006-06-15 Peppelenbosch Maikel P ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells
US20100273865A1 (en) * 2007-11-02 2010-10-28 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Polypeptides involved in neuronal regeneration-associated gene expression
US20110065100A1 (en) * 2009-09-16 2011-03-17 SwitchGear Genomics, Inc., a Delaware Corporation Transcription biomarkers of biological responses and methods

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BITA JAVAN ET AL.: ""Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system", ECANCER MEDICALSCIENCE, vol. 11, no. 751, JPN6025018144, 6 July 2017 (2017-07-06), pages 1 - 10, ISSN: 0005727810 *
BRIAN YEE HONG LAM ET AL.: ""CREB‐dependent Nur77 induction following depolarization in PC12 cells and neurons is modulated by", JOURNAL OF NEUROCHEMISTRY, vol. 112, no. 4, JPN6025018150, 20 January 2010 (2010-01-20), pages 1065 - 1073, ISSN: 0005727816 *
CHIA-HUNG CHEN ET AL.: ""A RAPID AND CONVENIENT METHOD TO ENHANCE TRANSGENIC EXPRESSION IN TARGET CELLS"", PREPARATIVE BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 42, no. 5, JPN6025018142, September 2012 (2012-09-01), pages 448 - 461, ISSN: 0005727808 *
HANI CHOUDHRY ET AL.: ""Advances in Hypoxia-Inducible Factor Biology"", CELL METABOLISM, vol. 27, no. 2, JPN6025018148, February 2018 (2018-02-01), pages 281 - 298, ISSN: 0005727814 *
JOHANNES SCHODEL ET AL.: ""High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq"", BLOOD, vol. 117, no. 23, JPN6025018147, 9 June 2011 (2011-06-09), pages 207 - 217, ISSN: 0005727813 *
J-Y LEE ET AL.: ""A novel chimeric promoter that is highly responsive to hypoxia and metals"", GENE THERAPY, vol. 13, no. 10, JPN6025018145, 9 February 2006 (2006-02-09), pages 857 - 868, ISSN: 0005727811 *
KOH NAKAYAMA ET AL.: ""Regulation of Gene Expression under Hypoxic Conditions"", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 20, no. 3278, JPN6025018146, 3 July 2019 (2019-07-03), pages 1 - 15, ISSN: 0005727812 *
MONA JOHANNESSEN ET AL.: ""Synergistic activation of CREB-mediated transcription by forskolin and phorbol ester requires PKC", CELLULAR SIGNALLING, vol. 16, no. 10, JPN6025018149, October 2004 (2004-10-01), pages 1187 - 1199, ISSN: 0005727815 *
SHU-YI HO ET AL.: ""Development of a computational promoter with highly efficient expression in tumors"", BMC CANCER, vol. 18, no. 480, JPN6025018143, 27 April 2018 (2018-04-27), pages 1 - 15, ISSN: 0005727809 *

Also Published As

Publication number Publication date
CA3171636A1 (en) 2021-09-30
EP4127180A1 (en) 2023-02-08
CN115698300A (zh) 2023-02-03
WO2021191628A1 (en) 2021-09-30
AU2021240417A1 (en) 2022-10-20
US20230374526A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
AU2017313917B2 (en) CRISPR-Cas genome engineering via a modular AAV delivery system
KR102699584B1 (ko) 대안적 스플라이싱의 압타머 매개 조절에 의한 유전자 발현 제어
US7893240B2 (en) High level expression of recombinant human erythropoietin having a modified 5′-UTR
JP2021502058A (ja) Rnaを編集するための組成物および方法
KR20200003370A (ko) 림프구를 형질도입 및 팽창시키고 이들의 활성을 조절하기 위한 방법 및 조성물
US20220323612A1 (en) Gene therapy of neuronal ceroid lipofuscinoses
JP2022514465A (ja) 第ix因子を発現するレンチウイルスベクターの使用
JP2022513319A (ja) 予測可能かつ安定な導入遺伝子発現を有するssi細胞および形成の方法
US12472269B2 (en) Liver-specific inducible promoters and methods of use thereof
RS64585B1 (sr) Regulacija ekspresije gena putem aptamerima posredovane kontrole samodegradujućih ribozima
US20230374526A1 (en) Forskolin-inducible promoters and hypoxia-inducible promoters
TW202221119A (zh) Dna結合域轉活化子及其用途
US20250302992A1 (en) Polycistronic Expression of Gut Peptides
US20230167458A1 (en) Forskolin-inducible promoters and hypoxia-inducible promoters
Niessen et al. Novel diabetes mellitus treatment: mature canine insulin production by canine striated muscle through gene therapy
WO2019162942A1 (en) Compositions and methods for delivery and expression of small inhibitory peptides and use thereof
HK40056629A (en) Liver-specific inducible promoters and methods of use thereof
HK40056629B (en) Liver-specific inducible promoters and methods of use thereof
WO2025247180A1 (zh) 用于制备含较少非目的序列的环状rna的载体和方法
US20160122713A1 (en) Genetically-modified micro-organ secreting a therapeutic peptide and methods of use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240311

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260212

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260421